| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12265-017-9740-6 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s12265-017-9740-6 |
| P698 | PubMed publication ID | 28265882 |
| P50 | author | Didier Letourneur | Q38545565 |
| Isabelle Bataille | Q60299903 | ||
| P2093 | author name string | Teresa Simon-Yarza | |
| P2860 | cites work | Osteogenesis in transplants of bone marrow cells | Q71202383 |
| Long-term in vivo alterations of polyester vascular grafts in humans | Q73543489 | ||
| Modeling lipid uptake in expanded polytetrafluoroethylene vascular prostheses and its effects on mechanical properties | Q73883096 | ||
| Influence of topography on endothelialization of stents: clues for new designs | Q74187134 | ||
| Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study | Q83732473 | ||
| Aortobifemoral bypass grafting using expanded polytetrafluoroethylene stretch grafts in patients with occlusive atherosclerotic disease | Q84092490 | ||
| Improved endothelialization and reduced thrombosis by coating a synthetic vascular graft with fibronectin and stem cell homing factor SDF-1α | Q85027875 | ||
| Angiogenic therapy for cardiac repair based on protein delivery systems | Q85055700 | ||
| Tissue-engineered acellular small diameter long-bypass grafts with neointima-inducing activity | Q87243891 | ||
| How Biomaterials Can Influence Various Cell Types in the Repair and Regeneration of the Heart after Myocardial Infarction | Q26739723 | ||
| Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions | Q27001159 | ||
| The physiology of cardiovascular disease and innovative liposomal platforms for therapy | Q27002949 | ||
| Functional cardiac tissue engineering | Q27024431 | ||
| Polysaccharide nanosystems for future progress in cardiovascular pathologies | Q27025494 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Solid organ fabrication: comparison of decellularization to 3D bioprinting | Q28077142 | ||
| Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: five-year results of a prospective randomized multicenter clinical trial | Q28210568 | ||
| Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart | Q28264555 | ||
| Layer by layer three-dimensional tissue epitaxy by cell-laden hydrogel droplets | Q30477397 | ||
| Reduced collagen deposition in infarcted myocardium facilitates induced pluripotent stem cell engraftment and angiomyogenesis for improvement of left ventricular function | Q30513942 | ||
| In vitro engineering of vascularized tissue surrogates | Q30536172 | ||
| Bioengineering Human Myocardium on Native Extracellular Matrix. | Q30706278 | ||
| Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data | Q30896351 | ||
| Enhancement of the growth of human endothelial cells by surface roughness at nanometer scale | Q33188352 | ||
| VEGF targets the tumour cell | Q33573324 | ||
| Evidence that human cardiac myocytes divide after myocardial infarction | Q33950386 | ||
| The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. | Q34010010 | ||
| Biomaterial-microvasculature interactions | Q34057377 | ||
| Spontaneous assembly of a self-complementary oligopeptide to form a stable macroscopic membrane | Q34058519 | ||
| Improved endothelialization of NiTi alloy by VEGF functionalized nanocoating | Q34183651 | ||
| Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association | Q34505315 | ||
| Differentiation of pluripotent embryonic stem cells into cardiomyocytes. | Q34778309 | ||
| Clinical trials of cardiac repair with adult bone marrow- derived cells | Q34786321 | ||
| Cell sheet engineering for myocardial tissue reconstruction | Q35109248 | ||
| Tissue engineering therapy for cardiovascular disease | Q35140518 | ||
| "Second-generation" stem cells for cardiac repair | Q35205665 | ||
| Design properties of hydrogel tissue-engineering scaffolds | Q35503173 | ||
| Pushing the envelope in tissue engineering: ex vivo production of thick vascularized cardiac extracellular matrix constructs. | Q35589725 | ||
| Targeting In-Stent-Stenosis with RGD- and CXCL1-Coated Mini-Stents in Mice | Q36021173 | ||
| Tissue-Engineered Small Diameter Arterial Vascular Grafts from Cell-Free Nanofiber PCL/Chitosan Scaffolds in a Sheep Model | Q36088850 | ||
| Mesenchymal stem cell delivery into rat infarcted myocardium using a porous polysaccharide-based scaffold: a quantitative comparison with endocardial injection | Q36765397 | ||
| Human cardiospheres as a source of multipotent stem and progenitor cells | Q36882814 | ||
| Myocardial tissue engineering: a review. | Q37014360 | ||
| Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials. | Q37026285 | ||
| Skeletal myoblasts and cardiac repair | Q37054555 | ||
| Nitric oxide: a guardian for vascular grafts? | Q37887771 | ||
| Strategies for tissue engineering cardiac constructs to affect functional repair following myocardial infarction | Q37912067 | ||
| Endothelial progenitor cell capture stent: safety and effectiveness | Q38011752 | ||
| Biomaterial applications in cardiovascular tissue repair and regeneration | Q38048839 | ||
| Present status and future perspectives of heart transplantation | Q38101400 | ||
| Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling | Q38104143 | ||
| Cell sheet-based cardiac tissue engineering | Q38171770 | ||
| Cardiac tissue engineering: state of the art. | Q38179331 | ||
| Functional poly(ε-caprolactone) based materials: preparation, self-assembly and application in drug delivery | Q38180169 | ||
| PLGA: a unique polymer for drug delivery | Q38309875 | ||
| Heart regeneration after myocardial infarction using synthetic biomaterials. | Q38349515 | ||
| Self-assembling peptide-based delivery of therapeutics for myocardial infarction. | Q38470140 | ||
| Alginate biomaterial for the treatment of myocardial infarction: Progress, translational strategies, and clinical outlook: From ocean algae to patient bedside | Q38473347 | ||
| Three-dimensional cardiac tissue fabrication based on cell sheet technology | Q38484824 | ||
| In situ Endothelialization: Bioengineering Considerations to Translation. | Q38605831 | ||
| Techniques for the induction of human pluripotent stem cell differentiation towards cardiomyocytes. | Q38700082 | ||
| Emerging roles of hyaluronic acid bioscaffolds in tissue engineering and regenerative medicine | Q38740200 | ||
| Extracellular Matrix Scaffolds for Tissue Engineering and Regenerative Medicine | Q38824465 | ||
| Fucoidan promotes early step of cardiac differentiation from human embryonic stem cells and long-term maintenance of beating areas. | Q38846480 | ||
| Plasma functionalization of poly(vinyl alcohol) hydrogel for cell adhesion enhancement | Q39103165 | ||
| Surface engineering of cardiovascular stent with endothelial cell selectivity for in vivo re-endothelialisation | Q39478673 | ||
| Tissue engineered myoblast sheets improved cardiac function sufficiently to discontinue LVAS in a patient with DCM: report of a case | Q39671879 | ||
| Fibronectin-mediated endothelialisation of chitosan porous matrices | Q39823852 | ||
| Optimization of poly(L-lactic acid)/segmented polyurethane electrospinning process for the production of bilayered small-diameter nanofibrous tubular structures. | Q40210371 | ||
| Effect of a Novel Stent on Re-Endothelialization, Platelet Adhesion, and Neointimal Formation | Q40565115 | ||
| Vascular Repair by Circumferential Cell Therapy Using Magnetic Nanoparticles and Tailored Magnets. | Q40996850 | ||
| Direct Adsorption of Anti-CD34 Antibodies on the Nano-Porous Stent Surface to Enhance Endothelialization. | Q41984343 | ||
| Endothelial cells derived from circulating progenitors as an effective source to functional endothelialization of NaOH-treated poly(epsilon-caprolactone) films. | Q42524491 | ||
| Optimization and critical evaluation of decellularization strategies to develop renal extracellular matrix scaffolds as biological templates for organ engineering and transplantation. | Q42552605 | ||
| Cellular encapsulation enhances cardiac repair | Q42875580 | ||
| First human use of an allogeneic tissue-engineered vascular graft for hemodialysis access | Q43437010 | ||
| Myocardial layer-specific effect of myoblast cell-sheet implantation evaluated by tissue strain imaging | Q44258034 | ||
| Endothelialization and patency of RGD-functionalized vascular grafts in a rabbit carotid artery model | Q44441268 | ||
| Comparison of carbon-impregnated and standard ePTFE prostheses in extra-anatomical anterior tibial artery bypass: a prospective randomized multicenter study | Q45213318 | ||
| Dacron or ePTFE for femoro-popliteal above-knee bypass grafting: short- and long-term results of a multicentre randomised trial | Q46115377 | ||
| Pore size, tissue ingrowth, and endothelialization of small-diameter microporous polyurethane vascular prostheses | Q47438889 | ||
| Coated prostheses are associated with prolonged inflammation in aortic surgery: a cost analysis | Q47972207 | ||
| Evaluation of hemocompatibility and endothelialization of hybrid poly(vinyl alcohol) (PVA)/gelatin polymer films | Q48021705 | ||
| A comparison of adsorbed and grafted fibronectin coatings under static and dynamic conditions. | Q49102929 | ||
| Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. | Q50520323 | ||
| Aortocoronary endothelial cell-seeded polytetrafluoroethylene graft: 9-year patency. | Q51064163 | ||
| Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. | Q51281365 | ||
| Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. | Q51328566 | ||
| Enhanced Patency and Endothelialization of Small-Caliber Vascular Grafts Fabricated by Coimmobilization of Heparin and Cell-Adhesive Peptides. | Q51542234 | ||
| Customizable engineered blood vessels using 3D printed inserts. | Q51576476 | ||
| Inkjet printing of viable mammalian cells. | Q51662738 | ||
| Development of novel covered stents using salmon collagen. | Q51745745 | ||
| Transplantation of adipose tissue mesenchymal cells conjugated with VEGF-releasing microcarriers promotes repair in murine myocardial infarction. | Q51842282 | ||
| Cardiovascular progenitor-derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure. | Q52877053 | ||
| Elasticity assessment of electrospun nanofibrous vascular grafts: a comparison with femoral ovine arteries. | Q53079890 | ||
| The consequences of a failed femoropopliteal bypass grafting: comparison of saphenous vein and PTFE grafts. | Q53333813 | ||
| Characterization and preparation of bio-tubular scaffolds for fabricating artificial vascular grafts by combining electrospinning and a 3D printing system. | Q53347915 | ||
| Design of biomimetic vascular grafts with magnetic endothelial patterning | Q57183917 | ||
| Cardiopoietic Stem Cell Therapy in Heart Failure | Q57779306 | ||
| Tubular cationized pullulan hydrogels as local reservoirs for plasmid DNA | Q57954234 | ||
| A Novel Cross-linked Poly(vinyl alcohol) (PVA) for Vascular Grafts | Q58223850 | ||
| The evaluation of a small-diameter polysaccharide-based arterial graft in rats | Q58223857 | ||
| Cationized pullulan 3D matrices as new materials for gene transfer | Q60571828 | ||
| Enhanced Endothelialization of a New Stent Polymer Through Surface Enhancement and Incorporation of Growth Factor-Delivering Microparticles | Q61634107 | ||
| Influence of polysaccharide composition on the biocompatibility of pullulan/dextran-based hydrogels | Q63944658 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 180-193 | |
| P577 | publication date | 2017-03-06 | |
| P1433 | published in | Journal of Cardiovascular Translational Research | Q6294906 |
| P1476 | title | Cardiovascular Bio-Engineering: Current State of the Art. | |
| P478 | volume | 10 |
Search more.